细胞周期蛋白E与乳腺癌的内分泌治疗和预后
Cyclin E and its relationship with endocrine treatment and prognosis of breast cancer
摘要
细胞周期蛋白E(cyclin E)作为细胞进入S期的限速调节因子备受关注。研究表明,cyclin E与乳腺癌的内分泌治疗疗效和预后存在相关性,且与其他生物学指标相比,它与乳腺肿瘤预后的相关性更大。
Cyclin E is an important regulatory factor promoting cells to enter the S phase. Studies show that cyclin E has stronger correlation with the prognosis of breast cancer than other biomarkers and it is also correlated with curative effect of endocrine therapy of breast cancer.
出处
《国际肿瘤学杂志》
CAS
2009年第4期273-275,共3页
Journal of International Oncology
参考文献24
-
1Sutherland RL, Musgrove EA. Cyclins and breast cancer. J Mammary Gland Biol Neoplasia, 2004, 9(1) :95-104.
-
2Chappuis PO, Donato E, Coffin JR, et al. Cyclin E expression in breast cancer: predicting gerndine BRCA1 mutations, prognosis and response to treatment. Ann Oncol, 2005, 16(5) :735-742.
-
3Harwell RM, Mull BB, Porter DC, et aL Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. J Biol Chem, 2004, 279(13) :12695- 12705.
-
4Libertini SJ, Robinson BS, Dhillon NK, et al. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. Cancer Res, 2005, 65 ( 23 ) : 10700-10708.
-
5Akli S, Zheng PJ, Muhani AS, et al. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res, 2004, 64 (9) :3198-3208.
-
6Butt AJ, Caldon CE, McNeil CM, et al. Cell cycle machinery:links with genesis and treatment of breast cancer. Adv Exp Med Biol, 2008, 630 : 189-205.
-
7Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol, 2005, 15 (4) :319- 326.
-
8Wang L, Shao ZM. Cyclin E expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Invest, 2006, 24(6) :581-587.
-
9Milano A, Dal Lago L, Sotiriou C, et al. What clinicians need to know about antioestrogen resistance in breast cancer therapy. Eur J Cancer, 2006, 42(16) :2692-2705.
-
10Butt A J, McNeil CM, Musgrove EA, et al. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer, 2005, 12 Suppl 1 :S47-59.
-
1石小燕,胡国清,曹荣华.细胞周期素D1和Ki67在鼻咽癌中的表达及意义[J].中华放射肿瘤学杂志,2003,12(4):273-274. 被引量:14
-
2张宣义,施仲义,胡建平,谢炳銮.CyclinE在人胃癌组织中的表达研究及其意义探讨[J].中国初级卫生保健,2013,27(6):137-138. 被引量:1
-
3房丽君,李剑.来源于间充质干细胞的CAFs促进肿瘤生长[J].基础医学与临床,2014,34(10):1442-1445. 被引量:4
-
4李伟,陶凯雄.hTERT表达的表观遗传调控研究进展[J].世界华人消化杂志,2010,18(10):1026-1031. 被引量:3
-
5张伟,杜成友,徐尔侃.肝癌临床发展与cyclin D1表达DNA含量及细胞凋亡发生的关系[J].第三军医大学学报,2005,27(5):467-468. 被引量:5
-
6陈立梅,杜瑞红.人端粒酶逆转录酶hTERT在肿瘤治疗研究中的进展[J].深圳中西医结合杂志,2004,14(5):307-309. 被引量:1
-
7方海洋(综述),李群星(审校).eIF4E与胃癌[J].国际肿瘤学杂志,2009,36(4):291-293. 被引量:1
-
8马双慰,吴凯南.细胞周期素D_1与乳腺癌[J].肿瘤防治杂志,2001,8(3):321-323.
-
9杨艳,于廷和.ERCC1与顺铂耐药的研究进展[J].肿瘤,2007,27(12):1008-1009. 被引量:10
-
10曾妍,章程,曲立科,寿成超.肿瘤转移灶克隆形成机制的研究进展[J].肿瘤,2013,33(2):202-206. 被引量:3